Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease

医学 安慰剂 不利影响 随机对照试验 内科学 临床痴呆评级 痴呆 认知功能衰退 生物标志物 临床试验 神经心理学 认知 评定量表 疾病 心理学 精神科 病理 发展心理学 化学 替代医学 生物化学
作者
Reisa A. Sperling,David Henley,Paul S. Aisen,Rema Raman,Michael Donohue,Karin Ernström,Michael S. Rafii,Johannes Streffer,Yingqi Shi,Keith Karcher,Nandini Raghavan,Yevgen Tymofyeyev,Jennifer Bogert,H. Robert Brashear,Gerald Novak,John Thipphawong,Ziad S. Saad,Hartmuth C. Kolb,Hany Rofael,Panna Sanga,Gary Romano
出处
期刊:JAMA Neurology [American Medical Association]
卷期号:78 (3): 293-293 被引量:66
标识
DOI:10.1001/jamaneurol.2020.4857
摘要

Atabecestat, a nonselective oral β-secretase inhibitor, was evaluated in the EARLY trial for slowing cognitive decline in participants with preclinical Alzheimer disease. Preliminary analyses suggested dose-related cognitive worsening and neuropsychiatric adverse events (AEs).To report efficacy, safety, and biomarker findings in the EARLY trial, both on and off atabecestat treatment, with focus on potential recovery of effects on cognition and behavior.Randomized, double-blind, placebo-controlled, phase 2b/3 study conducted from November 2015 to December 2018 after being stopped prematurely. The study was conducted at 143 centers across 14 countries. Participants were permitted to be followed off-treatment by the original protocol, collecting safety and efficacy data. From 4464 screened participants, 557 amyloid-positive, cognitively normal (Clinical Dementia Rating of 0; aged 60-85 years) participants (approximately 34% of originally planned 1650) were randomized before the trial sponsor stopped enrollment.Participants were randomized (1:1:1) to atabecestat, 5 mg (n = 189), 25 mg (n = 183), or placebo (n = 185).Primary outcome: change from baseline in Preclinical Alzheimer Cognitive Composite score. Secondary outcomes: change from baseline in the Cognitive Function Index and the Repeatable Battery for the Assessment of Neuropsychological Status total scale score. Safety was monitored throughout the study.Of 557 participants, 341 were women (61.2%); mean (SD) age was 70.4 (5.56) years. In May 2018, study medication was stopped early owing to hepatic-related AEs; participants were followed up off-treatment for 6 months. Atabecestat, 25 mg, showed significant cognitive worsening vs placebo for Preclinical Alzheimer Cognitive Composite at month 6 (least-square mean difference, -1.09; 95% CI, -1.66 to -0.53; P < .001) and month 12 (least-square mean, -1.62; 95% CI, -2.49 to -0.76; P < .001), and at month 3 for Repeatable Battery for the Assessment of Neuropsychological Status (least-square mean, -3.70; 95% CI, -5.76 to -1.63; P < .001). Cognitive Function Index participant report showed nonsignificant worsening at month 12. Systemic and neuropsychiatric-related treatment-emergent AEs were greater in atabecestat groups vs placebo. After stopping treatment, follow-up cognitive testing and AE assessment provided evidence of reversibility of drug-induced cognitive worsening and AEs in atabecestat groups.Atabecestat treatment was associated with dose-related cognitive worsening as early as 3 months and presence of neuropsychiatric treatment-emergent AEs, with evidence of reversibility after 6 months off treatment.ClinicalTrials.gov Identifier: NCT02569398.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lan发布了新的文献求助10
刚刚
1秒前
1秒前
1秒前
冬虫夏草完成签到,获得积分20
1秒前
hdd完成签到,获得积分10
2秒前
2秒前
Yzz完成签到,获得积分10
2秒前
ff发布了新的文献求助10
2秒前
嘻嘻完成签到,获得积分10
2秒前
2秒前
121完成签到,获得积分10
4秒前
4秒前
4秒前
4秒前
耍酷的白梦完成签到,获得积分10
4秒前
华仔应助灵巧一笑采纳,获得10
4秒前
小猪发布了新的文献求助10
5秒前
月亮moon完成签到,获得积分10
5秒前
114555发布了新的文献求助10
5秒前
夜雨完成签到,获得积分10
5秒前
小心完成签到,获得积分10
6秒前
Muran完成签到,获得积分0
6秒前
深情安青应助忐忑的邑采纳,获得10
7秒前
zz完成签到,获得积分10
8秒前
handsomeboy发布了新的文献求助10
8秒前
led应助火星上向珊采纳,获得50
8秒前
Szz完成签到,获得积分10
8秒前
ning完成签到,获得积分10
9秒前
lllllxy完成签到,获得积分10
9秒前
执笔完成签到,获得积分10
9秒前
吃肉璇璇发布了新的文献求助10
9秒前
JT1021O完成签到,获得积分10
10秒前
10秒前
开心颜发布了新的文献求助10
10秒前
驰驰发布了新的文献求助10
10秒前
10秒前
121发布了新的文献求助10
10秒前
dd123发布了新的文献求助10
11秒前
12秒前
高分求助中
좌파는 어떻게 좌파가 됐나:한국 급진노동운동의 형성과 궤적 2500
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Cognitive linguistics critical concepts in linguistics 800
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
氟盐冷却高温堆非能动余热排出性能及安全分析研究 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3052912
求助须知:如何正确求助?哪些是违规求助? 2710137
关于积分的说明 7419790
捐赠科研通 2354754
什么是DOI,文献DOI怎么找? 1246249
科研通“疑难数据库(出版商)”最低求助积分说明 606002
版权声明 595975